Number IV erythema multiforme

被引:56
作者
Farthing, P
Bagan, JV
Scully, C
机构
[1] UCL, Eastman Dent Inst, London WC1X 8LD, England
[2] Univ Sheffield, Charles Clifford Dent Sch, Sheffield, S Yorkshire, England
[3] Univ Valencia, Univ Hosp, E-46003 Valencia, Spain
关键词
erythema multiforme; autoimmune; immunosuppressants; oral; vesiculobullous; skin;
D O I
10.1111/j.1601-0825.2005.01141.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Erythema multiforme (EM) is an acute mucocutaneous hypersensitivity reaction characterised by a skin eruption, with or without oral or other mucous membrane lesions. Occasionally EM may involve the mouth alone. EM has been classified into a number of different variants based on the degree of mucosal involvement and the nature and distribution of the skin lesions. EM minor typically affects no more than one mucosa, is the most common form and may be associated with symmetrical target lesions on the extremities. EM major is more severe, typically involving two or more mucous membranes with more variable skin involvement-which is used to distinguish it from Stevens-Johnson syndrome (SJS), where there is extensive skin involvement and significant morbidity and a mortality rate of 5-15%. Both EM major and SJS can involve internal organs and typically are associated with systemic symptoms. Toxic epidermal necrolysis (TEN) may be a severe manifestation of EM, but some experts regard it as a discrete disease. EM can be triggered by a number of factors, but the best documented is preceding infection with herpes simplex virus (HSV), the lesions resulting from a cell mediated immune reaction triggered by HSV-DNA. SJS and TEN are usually initiated by drugs, and the tissue damage is mediated by soluble factors including Fas and FasL.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 45 条
[1]  
Abdollahi Mohammad, 2003, J Contemp Dent Pract, V4, P10
[2]   Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand [J].
Abe, R ;
Shimizu, T ;
Shibaki, A ;
Nakamura, H ;
Watanabe, H ;
Shimizu, H .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1515-1520
[3]   DETECTION OF HSV-SPECIFIC DNA IN BIOPSY-TISSUE OF PATIENTS WITH ERYTHEMA MULTIFORME BY POLYMERASE CHAIN-REACTION [J].
ASLANZADEH, J ;
HELM, KF ;
ESPY, MJ ;
MULLER, SA ;
SMITH, TF .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :19-23
[4]   Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study [J].
Auquier-Dunant, A ;
Mockenhaupt, M ;
Naldi, L ;
Correia, O ;
Schroder, W ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2002, 138 (08) :1019-1024
[5]  
Aurelian L, 2003, Dermatol Online J, V9, P1
[6]   Oral manifestations of erythema multiforme [J].
Ayangco, L ;
Rogers, RS .
DERMATOLOGIC CLINICS, 2003, 21 (01) :195-+
[7]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[8]   Immunomodulatory properties of interferon-γ -: An update [J].
Billiau, A ;
Heremans, H ;
Vermeire, K ;
Matthys, P .
MOLECULAR MECHANISMS OF FEVER, 1998, 856 :22-32
[9]   DETECTION OF HERPES-SIMPLEX VIRUS-DNA IN CUTANEOUS LESIONS OF ERYTHEMA MULTIFORME [J].
BRICE, SL ;
KRZEMIEN, D ;
WESTON, WL ;
HUFF, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (01) :183-187
[10]  
Carrozzo M, 1999, Minerva Stomatol, V48, P217